Pharmaceuticals - Community Register

  

Community list of not active orphan medicinal products


WITHDRAWN  

Product information

Deuterium oxide

EU orphan designation number: EU/3/04/239
Active ingredient: Deuterium oxide
Indication: Treatment of pancreatic cancer
Sponsor: BDD Berolina Drug Development GmbH
Bitterfelder Straße 19, D-12681 Berlin, Deutschand

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
22/11/2004 Centralised Orphan - Designation EMEA/OD/040/04 (2004)4187 of 20/10/2004
19/05/2009 Centralised Orphan - Removal of orphan designation from Community Register